CNBC   |  July 15, 2014

Next global epidemic?

CNBC's Meg Tirrell reports which biotech companies are working on what analysts say could be the next big biotech catalyst known as NASH, or nonalcoholic steatohepatitis.

Share This:

Sorry, we do not have a transcript available for this video at this time.